Brokerages expect Sapiens International Co. (NASDAQ:SPNS) to announce sales of $71.50 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Sapiens International’s earnings. The highest sales estimate is $72.40 million and the lowest is $70.60 million. Sapiens International reported sales of $57.11 million during the same quarter last year, which indicates a positive year over year growth rate of 25.2%. The business is expected to issue its next quarterly earnings results before the market opens on Tuesday, February 27th.
On average, analysts expect that Sapiens International will report full year sales of $71.50 million for the current year, with estimates ranging from $268.20 million to $272.00 million. For the next year, analysts anticipate that the firm will report sales of $281.44 million per share, with estimates ranging from $280.37 million to $282.50 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Sapiens International.
Several analysts recently issued reports on SPNS shares. BidaskClub raised shares of Sapiens International from a “strong sell” rating to a “sell” rating in a report on Wednesday, December 27th. Zacks Investment Research downgraded shares of Sapiens International from a “hold” rating to a “sell” rating in a report on Friday, January 5th. Finally, Barclays downgraded shares of Sapiens International from an “overweight” rating to an “equal weight” rating in a report on Friday. Two research analysts have rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $15.00.
Several hedge funds and other institutional investors have recently bought and sold shares of SPNS. Kingfisher Capital LLC bought a new stake in Sapiens International in the 4th quarter valued at $118,000. ARK Investment Management LLC bought a new stake in Sapiens International in the 4th quarter valued at $213,000. Jane Street Group LLC boosted its holdings in Sapiens International by 58.5% in the 3rd quarter. Jane Street Group LLC now owns 25,690 shares of the technology company’s stock valued at $339,000 after purchasing an additional 9,485 shares during the period. Dimensional Fund Advisors LP bought a new stake in Sapiens International in the 2nd quarter valued at $358,000. Finally, Menora Mivtachim Holdings LTD. bought a new stake in Sapiens International in the 3rd quarter valued at $402,000. 8.44% of the stock is owned by institutional investors and hedge funds.
Shares of Sapiens International (NASDAQ:SPNS) opened at $9.16 on Tuesday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.03 and a current ratio of 2.03. The stock has a market cap of $450.81, a price-to-earnings ratio of 458.00, a P/E/G ratio of 4.41 and a beta of 0.98. Sapiens International has a 1-year low of $9.14 and a 1-year high of $15.46.
ILLEGAL ACTIVITY NOTICE: “$71.50 Million in Sales Expected for Sapiens International Co. (SPNS) This Quarter” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://ledgergazette.com/2018/03/15/71-50-million-in-sales-expected-for-sapiens-international-co-spns-this-quarter.html.
About Sapiens International
Sapiens International Corporation N.V. (Sapiens) is a provider of software solutions for the insurance industry, with a focus on the financial services sector. The Company operates in provider of software solutions segment. Its software solutions portfolio consists of Life, Pension, Annuity and Retirement Solutions, including software solutions for the management of a range of products for life, pension, annuity and retirement; Property and Casualty/General Insurance Solutions, including a software suite of solutions, supporting a range of business lines, including personal, commercial and specialty lines, as well as a solution for the management of reinsurance contracts; Sapiens DECISION, which is a business decision management solution, and Technology-Based Solutions, such as Sapiens eMerge.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.